Position in GILD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,636,734
-$152,219 QoQ
Shares Held
12,955
+0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#896
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RFG Advisory, LLC holds $46,810,911 across 13 Drug Manufacturers - General names. GILD ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,775 | $12,923,859 | |
| 2 | ABBV |
AbbVie Inc.
|
40,584 | $10,212,557 | |
| 3 | JNJ |
Johnson & Johnson
|
22,980 | $5,836,230 | |
| 4 | AMGN |
Amgen Inc
|
14,031 | $5,080,905 | |
| 5 | NVO |
Novo Nordisk A S
|
66,135 | $3,170,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
20,666 | $2,655,581 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
35,462 | $2,043,320 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
12,955 | $1,636,734 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,636,734 | 12,955 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,788,953 | 12,836 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,620,781 | 13,205 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,434,342 | 12,922 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,414,701 | 12,760 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,498,556 | 13,374 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,284,866 | 13,910 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,117,503 | 13,329 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $810,970 | 11,820 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,649,150 | 22,514 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $1,560,657 | 19,265 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,277,427 | 17,046 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,601,360 | 20,778 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,596,093 | 19,237 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,627,887 | 18,962 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,186,668 | 19,236 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,130,566 | 18,291 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $587,841 | 9,888 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $720,581 | 9,924 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $611,327 | 8,752 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $594,674 | 8,636 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $560,148 | 8,667 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $614,409 | 10,546 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $478,221 | 7,568 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $536,964 | 6,979 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $266,893 | 3,570 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||